In addition, Innovent is the first Chinese biopharmaceutical company to receive clinical trial approval from US FDA for an anti-OX40 monoclonal antibody
.It has received US FDA's IND approvals for IBI308 (Sintilimab, an anti-PD-1 antibody) in January 2018 and IBI188 (an anti-CD47 antibody) in September 2018 respectively.
Another anti-IL-5 monoclonal antibody
is reslizumab, which decreases the sputum eosinophil number in patients who have been treated with mepolizumab for at least 1 year although it does not decrease the eosinophil number.
"Uveal effusion should be considered in patients taking anti-PD-1 and/or PD-L1 monoclonal antibody
therapy," the authors write.
The global monoclonal antibody
therapeutics market segmentation is based on source type (chimeric and humanized, human, murine, others), therapy type (antibody-directed enzyme prodrug therapy, antibody-drug conjugates, radioimmunotherapy), application (autoimmune diseases, cancer, hematological diseases, infection, ophthalmological diseases, others), and end user (hospitals, private clinics, research institutes).
[1.] Ecker DM, Jones SD, Levine HL (2014) The therapeutic monoclonal antibody
In the future, the study suggests adding monoclonal antibody
therapy to the regimen could reduce the need for such lengthy chemotherapy while still achieving the same or better survival rates.
"With the monoclonal antibody
programs that have emerged from iPierian, we see promising opportunities to create value with novel medicines from two companies, each focused on areas of high unmet need--neurodegenerative and rare diseases--where there is strong support by the phanna industry and the medical community for innovative drug development," said Rajeev Dadoo of SR One.
Peter Coleman, chief executive officer of Cobra Biologics, said, "We are delighted that Algeta has chosen Cobra as the manufacturer of a monoclonal antibody
. Algeta's contract forms part of a very successful year where we are seeing significant expansion in our antibody contract manufacturing as customers see the advantages Cobra's comprehensive services provide."
Washington, September 2 ( ANI ): A monoclonal antibody
therapy developed by MassBiologics of the University of Massachusetts Medical School (UMMS) and tested in an animal model at the Texas Biomedical Research Institute, prevents infection by the hepatitis C virus (HCV).
* Brodalumab (AMG 827) is a human monoclonal antibody
that binds to and blocks signaling via the IL-17 receptor.
drugs are a relatively new innovation in cancer treatment.
Three important monoclonal antibody
treatments are slated to lose patent protection by 2015: Roche Holding AG's (Basel CHE) Herceptin for cancer, Biogen Idec Inc.